跳至主要内容
临床试验/NCT03809494
NCT03809494终止不适用

Clinical Study of the Use of an Autologous Blood Filtration Device in the Treatment of Critical Limb Ischemia

Cook Research Incorporated6 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2019年7月23日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
6
主要终点
Freedom from vascular or endovascular arterial intervention below the knee of the study leg

研究概览

简要总结

The primary objective of this study is to evaluate the performance of the HemaTrate™ Blood Filtration system in the treatment of critical limb ischemia. The primary endpoint measure is comparing the percentage of patients between the treatment arm and control arm who have freedom from major amputation, arterial intervention below the knee, and death through 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

The investigator for this study is the person that will be performing the injections throughout the study and will know the participant's treatment (TNC or saline). The investigator that is aware of the participant's treatment will not be performing the follow-up visits.

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Critical Limb Ischemia in the study leg with ischemic rest pain and/or ulcer/minor tissue loss (Rutherford 4 or 5)
  • Previously failed an endovascular or surgical treatment of the study lower leg and is not being considered for additional intervention within the next 3 months OR is unsuitable for revascularization

排除标准

  • Simultaneously participating in another investigational study (e.g., drug or device)
  • Pregnant or breastfeeding, or planning to become pregnant within the next 12 months
  • Major surgery (open cardiac, vascular, or abdominal procedure) within the past 90 days
  • Endovascular intervention within the past 30 days
  • Current dialysis, or expected to need dialysis within the next 12 months
  • Previous above the ankle amputation in the study leg

结局指标

主要结局

Freedom from vascular or endovascular arterial intervention below the knee of the study leg

时间窗: 12 months

Percent of patients that have vascular or endovascular arterial intervention reported below the knee of the study leg

Death

时间窗: 12 months

Percent of patients that exit due to death

Freedom from major amputation of the study leg

时间窗: 12 months

Percent of patients that have any amputation above the ankle of the study leg

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

HemaTrate™ in the Treatment of Critical Limb Ischemia | 临床试验